Evaluation of COPD (Chronic Obstructive Pulmonary Disease) to Longitudinally Identify Predictive Surrogate Endpoints

GSK Investigational Site, Sofia

GSK Investigational Site, Hvidovre

GSK Investigational Site, Kiev

GSK Investigational Site, Golnik

GSK Investigational Site, Pleven

GSK Investigational Site, Wellington

GSK Investigational Site, Pittsburgh

GSK Investigational Site, Baltimore

GSK Investigational Site, Richmond

GSK Investigational Site, Miami

GSK Investigational Site, Rochester

GSK Investigational Site, Saint Charles

GSK Investigational Site, Omaha

GSK Investigational Site, Omaha

GSK Investigational Site, Houston

GSK Investigational Site, San Antonio

GSK Investigational Site, Denver

GSK Investigational Site, Donetsk

GSK Investigational Site, Phoenix

GSK Investigational Site, Torrance

GSK Investigational Site, Rancho Mirage

GSK Investigational Site, Hartford

GSK Investigational Site, New Haven

GSK Investigational Site, Boston

GSK Investigational Site, Boston

GSK Investigational Site, Lebanon

GSK Investigational Site, Providence

GSK Investigational Site, Vancouver

GSK Investigational Site, Vancouver

GSK Investigational Site, Halifax

GSK Investigational Site, Hamilton

GSK Investigational Site, Kingston

GSK Investigational Site, Montreal

GSK Investigational Site, Sainte-Foy

GSK Investigational Site, Prague

GSK Investigational Site, Horn

GSK Investigational Site, Bergen

GSK Investigational Site, Palma de Mallorca

GSK Investigational Site, Kiev

GSK Investigational Site, Edinburgh

GSK Investigational Site, Cambridge

GSK Investigational Site, Liverpool

GSK Investigational Site, London

GSK Investigational Site, Manchester